Dr. Julia Caitlin Espel, MD Internal Medicine - Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 11900 Southwest Hwy, Palos Park, IL 60464 Phone: 708-274-4900 Fax: 708-274-4949 |
Dr. Craig H Adams, MD Internal Medicine - Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 11900 Southwest Hwy, Palos Park, IL 60464 Phone: 708-274-4900 Fax: 708-274-4949 |
Dr. Antanas G Razma, MD Internal Medicine - Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 11900 Southwest Hwy, Palos Park, IL 60464 Phone: 708-274-4900 Fax: 708-274-4949 |
News Archive
There is still no cure for asthma, so for 22 million people in the U.S., this chronic disease continues to be a daily burden no matter where they live. But it's not just air pollution they should be worried about. Factors such as pollen, secondhand smoke – even high rates of poverty, a large uninsured population or a high number of ER visits – can be critical signs that certain cities and states are worse for families with asthma. It is especially true for people with severe asthma.
DNA testing for gene variants that can increase the risk of major coronary events in certain patients taking the anti-clotting drug Plavix® (clopidogrel bisulfate) is now being performed by Quest Diagnostics for Scripps Health patients electing to undergo coronary stent procedures.
Pathway Medical Technologies, Inc., an innovator of endovascular treatments for peripheral vascular disease (PVD), today announced that the U.S. Food & Drug Administration (FDA) has granted the company 510(k) clearance to market JETSTREAM G3™ SF (Small Fixed), the newest version of its peripheral revascularization catheter for the treatment of PVD.
The air in some school classrooms may contain higher levels of extremely small particles of pollutants - easily inhaled deep into the lungs - than polluted outdoor air, scientists in Australia and Germany are reporting in an article in ACS' semi-monthly journal Environmental Science & Technology.
WHO reports unprecedented progress against 17 neglected tropical diseases, thanks to a new global strategy, a regular supply of quality assured, cost-effective medicines and support from global partners.
› Verified 4 days ago